New antiplatelet agents for acute coronary syndromes

被引:28
作者
Ferguson, JJ
Lau, TK
机构
[1] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77225 USA
[2] Univ Texas, Hlth Sci Ctr, Houston, TX USA
[3] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1016/S0002-8703(98)70249-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S194 / S200
页数:7
相关论文
共 40 条
[21]  
KOTTKEMARCHANT K, 1995, CIRCULATION S1, V92, P488
[22]  
LEADLEY RJ, 1995, CIRCULATION S1, V92, P488
[23]   Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction [J].
Lefkovits, J ;
Ivanhoe, RJ ;
Califf, RM ;
Bergelson, BA ;
Anderson, KM ;
Stoner, GL ;
Weisman, HF ;
Topol, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (12) :1045-1051
[24]   Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization [J].
Lincoff, AM ;
Califf, RM ;
Anderson, KM ;
Weisman, HF ;
Aguirre, FV ;
Kleiman, NS ;
Harrington, RA ;
Topol, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (01) :149-156
[25]   ANTIPLATELET MONOCLONAL F(AB')2 ANTIBODY DIRECTED AGAINST THE PLATELET GPIIB-IIIA RECEPTOR COMPLEX PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CANINE HEART [J].
MICKELSON, JK ;
SIMPSON, PJ ;
LUCCHESI, BR .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1989, 21 (04) :393-405
[26]  
Ohman EM, 1997, CIRCULATION, V95, P846
[27]  
*PARAGON INV, 1996, CIRCULATION, V94, P553
[28]  
Simoons ML, 1997, LANCET, V349, P1429
[29]  
Simpfendorfer Conrad, 1996, Journal of the American College of Cardiology, V27, p242A
[30]   ANTITHROMBOTIC THERAPY IN CARDIAC DISEASE - AN EMERGING APPROACH BASED ON PATHOGENESIS AND RISK [J].
STEIN, B ;
FUSTER, V ;
HALPERIN, JL ;
CHESEBRO, JH .
CIRCULATION, 1989, 80 (06) :1501-1513